Skip to main content
. 2018 May 8;57(8):1481–1489. doi: 10.1093/rheumatology/key101

Table 2.

Most significant associations identified in the integrative gene set analysis

Gene Ontology annotation DMR RNA Prot FDR
N FC P-value N FC P-value N FC P-value
Extracellular matrix organization* 30 1.71 0.0026 40 1.48 0.0049 22 1.90 0.0072 0.0034
Gluconeogenesis 4 0.98 0.71 7 1.13 0.52 19 3.90 0.00001 0.0034
Positive regulation of cytosolic calcium ion concentration 11 1.44 0.081 20 2.45 0.00001 3 1.85 0.24 0.0034
Skeletal system development* 22 2.02 0.0012 28 1.53 0.0028 12 2.27 0.002 0.0034
Inflammatory response 19 1.07 0.40 44 1.89 0.00001 8 1.09 0.43 0.0081
Endodermal cell differentiation* 9 2.55 0.0054 12 2.14 0.0056 6 2.11 0.036 0.011
Positive regulation of ERK1 and ERK2 cascade* 19 1.60 0.014 21 1.53 0.013 11 2.17 0.0042 0.012
Positive regulation of peptidyl-tyrosine phosphorylation 10 1.61 0.079 18 1.94 0.0017 7 2.46 0.0032 0.012
Collagen catabolic process 16 2.27 0.0024 12 1.15 0.32 13 2.46 0.0013 0.012
Platelet aggregation* 8 1.95 0.048 12 1.71 0.027 11 2.71 0.002 0.016

All shown Gene Ontology terms are enriched in the cross-omics analysis at below 2% FDR. DMR: differentially methylated region; RNA: gene expression; Prot: protein abundance; N: number of significant genes annotated to GO term; FC: fold-change enrichment; P: within-omics empirical P-values for enrichment. FDR: integrative false-discovery rate based on combination of the three-omics P-values (see Methods section).

*

The terms with enrichment P < 0.05 across all individual omics analyses.